RT Journal Article SR Electronic T1 Mesterolone: a new androgen JF Drug and Therapeutics Bulletin JO Drug Ther Bull FD BMJ Publishing Group Ltd SP 58 OP 59 DO 10.1136/dtb.10.15.58 VO 10 IS 15 YR 1972 UL http://dtb.bmj.com/content/10/15/58.abstract AB Mesterolone (Pro-Viron) is an orally active androgen used in some countries since 1966 and recently introduced into Britain. It is being promoted for the treatment of male hypogonadism with the claim that, unlike other androgens that are effective orally, it does not cause hepatic cholestasis nor does it inhibit pituitary gonadotrophin secretion.